The cholesterol pathway: impact on immunity and cancer

Ryan J. King(University of Nebraska Medical Center), Pankaj K. Singh(University of Nebraska Medical Center), Kamiya Mehla(University of Nebraska Medical Center)
Trends in Immunology
December 22, 2021
10.1016/j.it.2021.11.007
Cited by 207Open Access
Full Text

Abstract

Related Papers

The Inflammasome
Fabio Martinon, Kimberly Burns, Jürg Tschopp|Molecular Cell|2002|6k
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Peter Duewell, Hajime Kono, Katey J. Rayner et al.|Nature|2010|3.9k
The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease
Sawsan Youssef, Olaf Stüve, Juan C. Patarroyo et al.|Nature|2002|1.1k
Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma
Fabienne Guillaumond, Ghislain Bidaut, Mehdi Ouaïssi et al.|Proceedings of the National Academy of Sciences|2015|460
Oxysterols are agonist ligands of RORγt and drive Th17 cell differentiation
Pejman Soroosh, Jiejun Wu, Xiaohua Xue et al.|Proceedings of the National Academy of Sciences|2014|248